Meco Diagnostics
Developer of predictive biomarker technology designed to enable antifibrotic therapy for early-stage breast cancer treatment. The company offers a clinically validated companion diagnostic platform, i...
Valuation
$12M
Market implied
Share Price
N/A
Total Raised
$1.1M
Last Round
N/A
7 investors — free account required
Sign up free Investors
+7 other investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions
Company Details
Sector
Healthcare
Headquarters
San Diego, CA, United States
Founded
2022
Employees
6
Website
mecodiagnostics.com